You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Stroke neuroprotection with a recombinant fusion protein

    SBC: ARMAGEN TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 800,000 persons in the U.S. suffer an acute stroke each year. There presently is no neuroprotective agent that can be given to patients with acute stroke, and stroke is the third leading cause of death. The costs for rehabilitation of patients that survive a stroke are greater than $40 billion per year in the U.S. The reason that an effective neu ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  2. Recombinant Enzyme Fusion Protein for Lysosomal Storage

    SBC: ARMAGEN TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): There are over 40 lysosomal storage disorders, and most of these diseases affect adversely the central nervous system (CNS). The mainstay of treatment of the lysosomal storage disorders is enzyme replacement therapy (ERT). However, ERT is not effective for the brain, because the enzymes do not cross the brain capillary wall, which forms the blood-brain barrier ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  3. Targeted Paraoxonase Fusion Protein as a Neurotherapeutic for Nerve Gas Agents

    SBC: ARMAGEN TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Civilian populations are at risk for exposure to chemical nerve gas agents such as organophosphates (OPs). These compounds affect both the peripheral nervous system (PNS) and the central nervous system (CNS). The CNS is affected because the OPs are lipid-soluble small molecules that easily penetrate the brain, owing to transport across the blood-brain barrier ( ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  4. Safety of intraarticular N-acetylglucosamine

    SBC: ARTYX PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Osteoarthritis (OA) is the most prevalent joint disease, causing joint pain and dysfunction. OA is also associated with substantial co-morbidity and reduces life expectancy. Pharmacologic therapy is limited to symptom modification and disease-modifying therapies are currently not available. Furthermore, even symptom-modifying therapies are limited in efficacy a ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  5. A Real Time Monitoring System to Measure IOP in Glaucoma

    SBC: ASSENTI, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Assenti LLC is a 10-person start-up company formed out of collaborative research teams from the University of Louisville's Speed School of Engineering and the Department of Ophthalmology & Visual Sciences along with key industry partners. Assenti's enclosed SBIR Phase II application will allow us to continue our significant progress and momentum towards becomin ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  6. Enabling Hearing Aid Function on Digital Cell Phones

    SBC: AUDIGICOMM, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): In the last decade, hearing aid technology has advanced rapidly and digital hearing aids are now widely available. Paralleling the advancements in hearing aids has been the rapid development in wireless communications. Digital cell phone has become an indispensable tool that enables people to communicate wirelessly around the world. The acoustic characteristics ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  7. Sustained release depot pre-exposure prophylaxis in breast feeding populations

    SBC: AURITEC PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The broad long term goal of this project is to prevent mother to child transmission of HIV through breast feeding in resource poor countries. In the developing world, perinatal transmission is greatly reduced through relatively simple expedients such as dosing mother and child around the time of delivery with nevirapine. However breast feeding still accounts fo ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  8. Sustained Release Intravitreal Corticosteroid Injections

    SBC: AURITEC PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long term goal of this research is to reduce or eliminate blindness due to diseases of the back of the eye by developing sustained release intravitreal injectable formulations for anti-inflammatory drugs. In previous work, supported in part through SBIR Phase 1 and 2 funding, the Principal Investigator has developed the Vitrasert(r) sustained release implan ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  9. HOST RANGE DIVERSITY OF BACTERIOPHAGE FOR Y. PESTIS

    SBC: AvidBiotics Corp.            Topic: N/A

    DESCRIPTION (provided by applicant): Yersinia pestis, the bacterium responsible for plague, is a Category A pathogen, a significant biowarfare agent. If weaponized, it can easily gain direct access to the respiratory system to cause rapid death by pneumonic plague. Pneumonic plague has fatality rates over 50%, is highly contagious, and if the bacteria are engineered to resist antibiotics, is essen ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  10. Mobile Training of Skilled Support Personnel

    SBC: BANDEMAR NETWORKS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant) Skilled Service Personnel (SSP) support emergency response organizations during an emergency incident involving weapons of mass destruction and include laborers, operating engineers, carpenters, ironworkers, sanitation workers and utility workers. SSP called to an emergency incident rarely have recent detailed training on the chemical, biological, radiological, ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government